Location History:
- Mission Veijo, CA (US) (1996)
- Roanoke, TX (US) (1997)
- Mission Viejo, CA (US) (1992 - 2002)
Company Filing History:
Years Active: 1992-2002
Title: Inventor Spotlight: David L Meadows
Introduction:
David L Meadows, a brilliant inventor based in Mission Viejo, CA, has made significant contributions to the field of pharmaceutical and ophthalmic technology. With an impressive portfolio of 17 patents, Meadows has demonstrated a keen eye for innovation and a passion for advancing medical science.
Latest Patents:
1. Nonaqueous fluorinated drug delivery suspensions: Meadows' innovative patent discloses nonaqueous pharmaceutical compositions designed for use in aqueous physiological systems. These compositions feature drug delivery suspensions of nonaqueous perfluorocarbon or fluorinated silicone liquid carriers, enhancing bioavailability and stability of therapeutic or diagnostic compounds.
2. Diagnostics apparatus for determining precorneal retention time: Another groundbreaking patent by Meadows introduces an apparatus and method for measuring ophthalmic formulation retention on the surface of an eye. This technology involves dissolving a fluorescent macromolecule in an ophthalmic formulation to form a fluorescently labelled formulation, enabling precise measurement of formulation retention over time.
Career Highlights:
David L Meadows is currently affiliated with Allergan, Inc., a leading pharmaceutical company known for its innovative contributions to ophthalmology and aesthetics. His expertise and dedication have played a pivotal role in shaping the company's success and reputation for cutting-edge research and development.
Collaborations:
Meadows has had the privilege of working alongside accomplished professionals in his field, including Katherine C Kurjan and Larry E Branham. The collaborative efforts of Meadows and his coworkers have led to the creation of groundbreaking technologies that continue to impact the medical industry.
Conclusion:
Inventor David L Meadows stands as a shining example of ingenuity and expertise in the realm of pharmaceutical and ophthalmic innovation. His pioneering patents, successful career at Allergan, Inc., and fruitful collaborations underscore his unwavering commitment to advancing healthcare technologies and improving patient outcomes.